Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy
ClinicalTrials.gov study NCT02889523. IPD Sharing: NO. Countries: 2. Publications: 1.
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00769522. IPD Sharing: NO. Countries: 1. Publications: 6.
Polatuzumab Vedotin in Patients With Relapsed and Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT05006534. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
ClinicalTrials.gov study NCT04531046. IPD Sharing: NO. Countries: 2. Publications: 2.
Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT03372837. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
ClinicalTrials.gov study NCT01083563. IPD Sharing: Not stated. Countries: 1. Publications: 2.
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
ClinicalTrials.gov study NCT02537977. IPD Sharing: NO. Countries: 1. Publications: 0.
CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma
ClinicalTrials.gov study NCT03579927. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00499018. IPD Sharing: Not stated. Countries: 1. Publications: 2.
CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT03064269. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)
ClinicalTrials.gov study NCT04416984. IPD Sharing: NO. Countries: 3. Publications: 1.
Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
ClinicalTrials.gov study NCT04978584. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03808610. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL
ClinicalTrials.gov study NCT05507827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04314843. IPD Sharing: YES. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
ClinicalTrials.gov study NCT02456350. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV
ClinicalTrials.gov study NCT00466258. IPD Sharing: Not stated. Countries: 1. Publications: 24.
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
ClinicalTrials.gov study NCT05894512. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT03036904. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
ClinicalTrials.gov study NCT04663347. IPD Sharing: NO. Countries: 13. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.